A detailed history of Tower Research Capital LLC (Trc) transactions in Immunic, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,925 shares of IMUX stock, worth $4,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,925
Previous 16,974 76.88%
Holding current value
$4,239
Previous $18,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.08 - $1.95 $14,092 - $25,445
-13,049 Reduced 76.88%
3,925 $6,000
Q2 2024

Aug 13, 2024

SELL
$0.98 - $1.44 $25,095 - $36,875
-25,608 Reduced 60.14%
16,974 $18,000
Q1 2024

May 15, 2024

BUY
$1.14 - $1.53 $43,172 - $57,942
37,871 Added 803.88%
42,582 $56,000
Q4 2023

Feb 13, 2024

BUY
$0.97 - $1.6 $4,162 - $6,865
4,291 Added 1021.67%
4,711 $7,000
Q3 2023

Nov 14, 2023

SELL
$1.35 - $2.87 $9,979 - $21,215
-7,392 Reduced 94.62%
420 $0
Q2 2023

Aug 14, 2023

SELL
$1.33 - $2.51 $6,841 - $12,911
-5,144 Reduced 39.7%
7,812 $19,000
Q1 2023

May 09, 2023

SELL
$1.35 - $2.87 $21,602 - $45,925
-16,002 Reduced 55.26%
12,956 $19,000
Q4 2022

Feb 10, 2023

BUY
$1.13 - $10.8 $16,128 - $154,148
14,273 Added 97.19%
28,958 $40,000
Q3 2022

Nov 10, 2022

BUY
$3.0 - $5.49 $18,417 - $33,703
6,139 Added 71.83%
14,685 $46,000
Q2 2022

Aug 15, 2022

BUY
$3.13 - $12.25 $23,568 - $92,242
7,530 Added 741.14%
8,546 $29,000
Q1 2022

May 12, 2022

BUY
$9.54 - $14.26 $3,291 - $4,919
345 Added 51.42%
1,016 $11,000
Q4 2021

Feb 14, 2022

SELL
$7.34 - $10.25 $7,927 - $11,070
-1,080 Reduced 61.68%
671 $6,000
Q3 2021

Nov 15, 2021

SELL
$8.05 - $13.29 $119,252 - $196,878
-14,814 Reduced 89.43%
1,751 $15,000
Q2 2021

Aug 16, 2021

BUY
$11.76 - $16.85 $177,505 - $254,333
15,094 Added 1026.1%
16,565 $203,000
Q1 2021

May 17, 2021

SELL
$14.21 - $25.3 $88,485 - $157,543
-6,227 Reduced 80.89%
1,471 $24,000
Q4 2020

Feb 16, 2021

BUY
$14.8 - $20.37 $62,811 - $86,450
4,244 Added 122.87%
7,698 $118,000
Q3 2020

Nov 16, 2020

BUY
$11.74 - $22.0 $27,154 - $50,886
2,313 Added 202.72%
3,454 $64,000
Q2 2020

Aug 13, 2020

SELL
$5.67 - $15.86 $5,437 - $15,209
-959 Reduced 45.67%
1,141 $14,000
Q1 2020

May 15, 2020

BUY
$4.22 - $9.8 $3,376 - $7,840
800 Added 61.54%
2,100 $13,000
Q4 2019

Feb 07, 2020

BUY
$6.4 - $10.23 $4,416 - $7,058
690 Added 113.11%
1,300 $13,000
Q3 2019

Nov 05, 2019

SELL
$10.0 - $17.01 $23,000 - $39,123
-2,300 Reduced 79.04%
610 $6,000
Q2 2019

Aug 13, 2019

BUY
$7.88 - $33.2 $22,930 - $96,612
2,910 New
2,910 $33,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $33M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.